Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:45 PM
Ignite Modification Date: 2025-12-25 @ 9:38 PM
NCT ID: NCT05312151
Description: None
Frequency Threshold: 5
Time Frame: 12 Weeks
Study: NCT05312151
Study Brief: The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
COMP360 Psilocybin 25 mg COMP360 Psilocybin Psilocybin: Open label 0 None 0 22 22 22 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 26.1 View
Crying SYSTEMATIC_ASSESSMENT General disorders MedDRA 26.1 View
Chills SYSTEMATIC_ASSESSMENT General disorders MedDRA 26.1 View
COVID-19 SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 26.1 View
Muscle tightness SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 26.1 View
Myalgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 26.1 View
Tension headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 26.1 View
Paraesthesia SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 26.1 View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 26.1 View
Euphoric mood SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 26.1 View
Paranoia SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 26.1 View
Visual impairment SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 26.1 View
Fatigue SYSTEMATIC_ASSESSMENT General disorders MedDRA 26.1 View
Back pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 26.1 View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 26.1 View
Hallucination, visual SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 26.1 View
Suicidal ideation SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 26.1 View